KalshiVerificar disponibilidadeKYC obrigatório2% de taxaDados de resolução verificadosCalibração aproximadaProbabilidade implícita atualBefore October 2027 90%Líder entre 5 opções
Qualidade do mercado
48 / 100
Baixa qualidadeVolume 24h
0 €
Liquidez
6,5 mil €
Liquidez médiaCompra / Venda
32.0% / 36.0%
Spread
4.0 pt
Spread moderadoDados do mercado
Atualizado há 13 minutos
16/05/26, 2:301/01/27, 4:59
Tendências
Apenas fundos simulados, sem dinheiro realIsto não é aconselhamento financeiro
Resultado escolhido
Before Jan 1, 202736%
Tendência de volume
$132 de jul.20d de dados27 de jul.
Mercados Relacionados
Hantavirus pandemic in 2026?
98,4 mil €Sim: 3%
POLYMARKET
POLYMARKET
# of views of MrBeast video day 3?
6,9 mil €26-27M: 78%POLYMARKET
POLYMARKET
New pandemic in 2026?
5,2 mil €Sim: 9%POLYMARKET
POLYMARKET
Measles cases in 2026?
2,4 mil €Above 3000: 94%KALSHI
KALSHI
Pandemic in 2026?
2 mil €Sim: 5%KALSHI
KALSHI
Cyclosporiasis cases reported in the US in 2026?
1,2 mil €Above 20k: 34%KALSHI
KALSHIAtivos nestes tópicos
Regras
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.